CLDN6 and breast cancer: Furthermore, the Timer database (http://timer.cistrome.org/) elucidated a negative correlation between CLDN6 and SREBF1, as well as its downstream targets FASN, ACACA, and SCD, in BC (Supplementary Fig. 2C).